Abstract TH179: Systolic Blood Pressure Time in Target Range and Adverse Kidney Outcomes: A Systematic Review and Meta-Analysis
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.th179 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Hypertension, 2026-10. Verfasst von Brett Cohen und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Time in target range (TTR) for systolic blood pressure (SBP) quantifies the consistency of blood pressure control over time and predicts cardiovascular events. Whether higher SBP-TTR protects the kidney is unsettled: a 2025 meta-analysis pooled TTR against cardiovascular and mortality endpoints but judged the renal evidence insufficient to pool. We performed the first meta-analysis of SBP-TTR and adverse kidney outcomes.
Methods
We systematically searched PubMed and Europe PMC (through June 2026) with backward and forward citation chaining for cohort studies and post-hoc randomized trial analyses reporting an adjusted association between SBP-TTR and a renal endpoint; non-blood-pressure "time in range" exposures (anticoagulation, glucose, body weight) were excluded. The primary analysis pooled adjusted hazard ratios (HRs) per 1-standard-deviation (SD) higher SBP-TTR for a composite of adverse kidney events (chronic kidney disease [CKD] progression, incident CKD, or acute kidney injury [AKI]) using random-effects (REML) models with Knapp-Hartung variance; heterogeneity was summarized with I-squared. A secondary analysis pooled highest-versus-lowest TTR category contrasts. Certainty was graded with GRADE.
Results
Three cohorts (SPRINT, STEP, and KNOW-CKD; 15,667 participants, approximately 1,559 events) reported per-1-SD estimates. Higher SBP-TTR was associated with lower risk of adverse kidney events (pooled HR 0.89, 95% CI 0.85-0.93; I-squared 0%). The association was consistent when restricted to chronic CKD progression (HR 0.90, 95% CI 0.84-0.95) and across five studies in a highest-versus-lowest category analysis (HR 0.72, 95% CI 0.64-0.82). Leave-one-out estimates were stable (0.88-0.90).
Conclusions
Greater consistency of systolic blood pressure control, measured as time in target range, was associated with roughly 11% lower risk of adverse kidney events per SD increase, with no detectable heterogeneity and a consistent dose-response gradient (moderate-certainty evidence, GRADE). Findings are limited by the small number of cohorts and possible reverse causation. SBP-TTR may serve as a modifiable quality metric for kidney protection and warrants prospective evaluation.
Zitieren
APA
Cohen, B., Singh, S. T., Majmundar, A., Allen, B., & Boardwine, B. (2026). Abstract TH179: Systolic Blood Pressure Time in Target Range and Adverse Kidney Outcomes: A Systematic Review and Meta-Analysis. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th179
Vancouver
Cohen B, Singh ST, Majmundar A, Allen B, Boardwine B. Abstract TH179: Systolic Blood Pressure Time in Target Range and Adverse Kidney Outcomes: A Systematic Review and Meta-Analysis. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th179
BibTeX
@article{Cohen2026,
author = {Cohen, Brett and Singh, Saran T and Majmundar, Aarjuv and Allen, Bryce and Boardwine, Brendan},
title = {Abstract TH179: Systolic Blood Pressure Time in Target Range and Adverse Kidney Outcomes: A Systematic Review and Meta-Analysis},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.th179}
}
EUVIMED